Lancet Market Report 2026

Lancet Market Overview

• Lancet market size has reached to $2.8 billion in 2025 • Expected to grow to $4.71 billion in 2030 at a compound annual growth rate (CAGR) of 10.9% • Growth Driver: Growing Prevalence Of Diabetes Driving The Market Growth Due To Rising Need For Blood Glucose Monitoring • Market Trend: Innovative Hidden-Needle Lancing Devices Enhancing Safety And Comfort In Blood Sampling • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Lancet Market?

Lancet refers to a small, sharp, double-edged surgical instrument typically used for making quick, precise incisions or punctures in the skin, most commonly used in procedures such as blood sampling, abscess drainage, or minor surgeries, and is an essential tool in both clinical and laboratory settings due to its ease of use, sterilizability, and effectiveness in minimizing tissue damage. The main types of lancets include safety lancets, push button safety lancets, pressure activated safety lancets, side button safety lancets, and personal lancets. A safety lancet is a single-use device with an automatic needle retraction feature designed to provide safe, hygienic, and low-pain blood sampling while minimizing the risk of needlestick injuries and cross-contamination. These lancets are available in various gauge sizes, including 22 gauge and below, 23 to 33 gauge, and above 33 gauge. They are used in applications such as glucose testing, hemoglobin testing, coagulation testing, cholesterol testing, allergy testing, neonatal testing, and others. The primary end users of these lancets include hospitals, clinics, ambulatory surgery centers, homecare settings, and others.

What Is The Lancet Market Growth Forecast?

The lancet market size is expected to see rapid growth in the next few years. It will grow to $4.71 billion in 2030 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to technological advancements in lancet design, adoption of homecare testing kits, integration with digital health platforms, expansion in emerging markets, increased regulatory support for safety devices. Major trends in the forecast period include miniaturization of medical devices, increased focus on patient safety, rising home healthcare adoption, growth in point-of-care diagnostics, eco-friendly & sustainable medical instruments.

What Is The Driver Of The Lancet Market?

The growing prevalence of diabetes is expected to propel the growth of the lancet market going forward. Diabetes is a chronic health condition that affects how the body turns food into energy due to problems with insulin production or use. The growing prevalence of diabetes is primarily due to unhealthy lifestyle habits such as poor diet, lack of physical activity, and increasing rates of obesity, which contribute to the development of insulin resistance and elevated blood sugar levels. Lancets help manage diabetes by enabling regular blood glucose monitoring through safe and precise fingertip pricking, which is essential for effective diabetes control, early detection of glucose fluctuations, and timely adjustments in medication, diet, or lifestyle to prevent complications. For instance, in June 2024, according to the National Health Service, a UK-based government department, in 2023, the NHS identified over half a million (549,000) additional individuals in England at risk of developing type 2 diabetes, bringing the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330. This represents a significant increase compared to 3,065,825 in 2022, highlighting a rise of nearly 20%. Therefore, the growing prevalence of diabetes is driving the growth of the lancet industry.

Key Players In The Global Lancet Market

Major companies operating in the lancet market are Cardinal Health Inc., F. Hoffmann-La Roche Ltd, Abbott Laboratories, Becton Dickinson and Company, Terumo Corporation, SARSTEDT AG & Co. KG, B. Braun Melsungen AG, Owen Mumford Limited, Amkay Products Pvt. Ltd, NARANG MEDICAL LIMITED, GBUK GROUP LIMITED, ARKRAY HEALTHCARE PRIVATE LIMITED, Sterimed Medical Devices Private Limited, MediPurpose Pte. Ltd, Carelife USA Inc., Shandong Lianfa Medical Plastic Products Co. Ltd, Ambimed Healthcare Private Limited, Greiner Bio-One International GmbH, Roche Diabetes Care GmbH, Ypsomed Holding AG, TaiDoc Technology Corporation, HTL STREFA S.A.

Global Lancet Market Trends and Insights

Major companies operating in the lancet market are focusing on leveraging innovative technologies such as total path control vertical-drive technology to improve sampling precision and reduce pain during blood collection. Total path control vertical-drive technology is a mechanism that guides the lancet needle in a straight, vertical path during insertion and retraction. This controlled motion minimizes lateral movement, reducing tissue damage, vibration, and pain, resulting in a more precise and comfortable blood sampling experience for the user. For instance, in July 2025, SteriLance Medical (Suzhou) Inc., a China-based medical device company, launched the OneStep lancing device and SoftSense lancets in Spain, introducing a cap-free, hidden-needle lancing solution that utilizes patent-protected total path control vertical-drive technology to deliver virtually painless blood sampling and enhance user safety. The one-step device features a four-step workflow, insert, twist, press, and eject, that simplifies the lancing process by reducing preparatory motions by approximately 70% compared to conventional lancing pens.

What Are Latest Mergers And Acquisitions In The Lancet Market?

In August 2024, MTD S.p.A., an Italy-based medical device company, acquired the Pen Needles and Blood Glucose Monitoring Systems (BGM) businesses of Ypsomed AG for an undisclosed amount. With this acquisition, MTD S.p.A. aims to strengthen its global leadership in diabetes and obesity care by expanding its portfolio with advanced pen needles, lancets, and blood glucose monitoring systems, boosting production capacity, and entering high-growth markets such as China and India while reinforcing its presence in North America and Europe. Ypsomed AG is a Switzerland-based manufacturing company that specializes in providing lancets and other self-injection systems.

What Defines the Lancet Market?

The lancet market consists of sales of adjustable-depth lancets, pediatric lancets, blood glucose testing kits, multi-lancet devices, and heel lancets. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Lancet Market Report 2026?

The lancet market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the lancet industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.